海正药业：已累计斥资5699.15万元回购0.51%股份

Core Viewpoint - The company, Haizheng Pharmaceutical, announced its fourth share repurchase plan, which will commence on May 12, 2025, and is expected to last until May 11, 2026, with a budget of 50 million to 100 million yuan for employee stock ownership plans or equity incentives [1] Summary by Categories Share Repurchase Plan - The company plans to repurchase shares through centralized bidding, with a total expected amount of 50 million to 100 million yuan [1] - The repurchase period is set from May 12, 2025, to May 11, 2026 [1] Current Repurchase Status - As of the end of October 2025, the company has repurchased a total of 6,115,000 shares, which accounts for 0.51% of the total share capital [1] - The total amount spent on repurchases so far is 56.9915 million yuan, with repurchase prices ranging from 8.92 yuan to 10.55 yuan per share [1]